A pilot study on total body irradiation using TomoTherapy IMRT prior to hematopoietic stem cell transplantatio

Not Applicable

• Conditions: Hematopoietic malignancy

• Registration Number: JPRN-UMIN000033248
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-03
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1. General condition unfit for Total Body Irradiation 28days prior to registration. 2. Patient with active disease 3. Active other cancers 4. Unable to tolerate fixation during Total Body Irradiation 5. Unfit for TomoTherapy irradiation due to technical reasons 6. Patient during pregnancy 7. History of allogeneic or autologous transplantation 8. Other cases in which investigators considered unfit for this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of Grade 3 or greater adverse events 3 months to 1 year following total body irradiation.